Cannabidiol study for anxiety and depression in bipolar disorder
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study tests whether cannabidiol (CBD) can reduce anxiety and depressive symptoms in people with bipolar disorder. It may help if your mood symptoms are persistent and you’re already on stable bipolar medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign informed consent
- You’re 18 to 65 years old
- You’re able to do the study in English
- You have bipolar I or bipolar II disorder diagnosed by DSM-5
- You currently have at least moderate anxiety symptoms
- You take your bipolar medicines on a stable schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether cannabidiol (CBD) can reduce symptoms of bipolar depression. You may be eligible if you have bipolar I or II and a current depressive episode while staying on approved mood-stabilizing or antipsychotic medication.
This trial studies whether cannabidiol (CBD) helps improve social anxiety symptoms. You may be able to join if you are an adult with significant social anxiety and meet medication and health safety requirements.
This early-phase study tests how cannabidiol (CBD) affects learning and anxiety. You may be able to join if you meet age and health requirements and have not used CBD or other cannabis recently.
This Phase 2 study tests cannabidiol (CBD) to calm inflammation in the brain that may be linked to chronic low back pain. If you qualify, you’ll take study CBD and undergo brain imaging to see whether inflammation changes.
This trial tests if cannabidiol (CBD) oil can help people with major depression that has not improved with standard antidepressants. You will take CBD oil or a placebo while continuing your current antidepressant treatment to see if it improves your symptoms.
This Phase 2 study tests whether cannabidiol (CBD) can safely reduce PTSD symptoms in adults. You may be eligible if you have a current PTSD diagnosis and can follow the study steps for the full time.
Hear when a new Bipolar Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.